HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chin-San Liu Selected Research

MERRF Syndrome (Myoclonic Epilepsy and Ragged Red Fibers)

12/2013Treatment of human cells derived from MERRF syndrome by peptide-mediated mitochondrial delivery.
1/2013Functional recovery of human cells harbouring the mitochondrial DNA mutation MERRF A8344G via peptide-mediated mitochondrial delivery.
12/2012FGF21 in ataxia patients with spinocerebellar atrophy and mitochondrial disease.
10/2007Magnetic resonance spectroscopy study in basal ganglia of patients with myoclonic epilepsy with ragged-red fibers.
5/2005High prevalence of the COII/tRNA(Lys) intergenic 9-bp deletion in mitochondrial DNA of Taiwanese patients with MELAS or MERRF syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Chin-San Liu Research Topics

Disease

13Neoplasms (Cancer)
02/2022 - 11/2008
11Mitochondrial Diseases (Mitochondrial Disease)
10/2020 - 05/2005
8Machado-Joseph Disease (Spinocerebellar Ataxia Type 3)
02/2022 - 01/2003
6Atherosclerosis
02/2020 - 11/2004
6Myocardial Infarction
11/2017 - 01/2013
5Stroke (Strokes)
02/2020 - 05/2005
5MERRF Syndrome (Myoclonic Epilepsy and Ragged Red Fibers)
12/2013 - 05/2005
4Parkinson Disease (Parkinson's Disease)
01/2021 - 09/2007
4Breast Neoplasms (Breast Cancer)
01/2020 - 09/2010
4Spinocerebellar Ataxias (Spinocerebellar Ataxia)
11/2019 - 12/2012
4Neurodegenerative Diseases (Neurodegenerative Disease)
02/2019 - 01/2008
4Inflammation (Inflammations)
11/2017 - 04/2012
4MELAS Syndrome (Syndrome, MELAS)
01/2017 - 05/2005
3Osteosarcoma (Osteogenic Sarcoma)
01/2022 - 06/2016
3Pelvic Organ Prolapse
07/2019 - 07/2009
3Ischemic Stroke
01/2018 - 05/2006
3Hypertension (High Blood Pressure)
01/2018 - 01/2011
3ST Elevation Myocardial Infarction
08/2016 - 01/2013
3Hypercholesterolemia
01/2016 - 02/2010
3Infections
10/2015 - 07/2008
3Lung Neoplasms (Lung Cancer)
12/2014 - 03/2009
3Cardiovascular Diseases (Cardiovascular Disease)
04/2012 - 11/2004
2Carotid Stenosis (Carotid Artery Stenosis)
02/2020 - 01/2018
2Neuroblastoma
10/2019 - 01/2016
2Diabetic Nephropathies (Diabetic Nephropathy)
12/2018 - 10/2015
2Hearing Loss (Hearing Impairment)
10/2018 - 12/2012
2Necrosis
11/2017 - 01/2016
2Ovarian Neoplasms (Ovarian Cancer)
06/2017 - 05/2014
2Intracranial Aneurysm (Cerebral Aneurysm)
09/2015 - 01/2015
2Aneurysm (Aneurysms)
09/2015 - 01/2015
2Rupture
01/2015 - 06/2010
2Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2015 - 11/2008
2B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2015 - 11/2008
2Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage)
01/2015 - 03/2007
2Myoclonic Epilepsies (Myoclonic Encephalopathy)
08/2014 - 01/2013
2Spinocerebellar Degenerations (Marinesco Sjogren Syndrome)
12/2012 - 12/2010
2Ataxia (Dyssynergia)
12/2012 - 12/2010
2Epilepsy (Aura)
09/2007 - 01/2002
1Atrophy
07/2021
1Parkinsonian Disorders (Parkinsonism)
01/2021
1Alopecia (Baldness)
10/2020
1Cerebral Infarction
02/2020
1Triple Negative Breast Neoplasms
01/2020
1Chronic Renal Insufficiency
10/2019
1Disease Progression
10/2019
1Prolapse
07/2019
1Cerebellar Diseases (Cerebellar Syndrome)
02/2019
1Type 2 Diabetes Mellitus (MODY)
12/2018
1Nonsyndromic Deafness
10/2018
1Deglutition Disorders (Dysphagia)
10/2018

Drug/Important Bio-Agent (IBA)

35Mitochondrial DNA (mtDNA)IBA
07/2019 - 05/2005
15Biomarkers (Surrogate Marker)IBA
02/2020 - 12/2010
10Proteins (Proteins, Gene)FDA Link
01/2021 - 03/2007
9Cyclophilin AIBA
02/2020 - 12/2013
7Peptides (Polypeptides)IBA
01/2017 - 01/2013
6DNA (Deoxyribonucleic Acid)IBA
10/2019 - 11/2008
6polyglutamineIBA
02/2019 - 01/2008
5Ataxin-3IBA
10/2019 - 01/2003
5Reactive Oxygen Species (Oxygen Radicals)IBA
11/2017 - 05/2010
4Cell-Penetrating PeptidesIBA
01/2019 - 01/2013
4alpha-TocopherolFDA Link
12/2014 - 11/2008
4beta Carotene (Betacarotene)FDA Link
12/2014 - 11/2008
4AntioxidantsIBA
01/2014 - 01/2002
4oxidized low density lipoproteinIBA
01/2013 - 05/2005
3Carbonic Anhydrases (Carbonic Anhydrase)IBA
01/2022 - 06/2016
3Pharmaceutical PreparationsIBA
01/2020 - 08/2014
3ResveratrolIBA
01/2018 - 01/2015
3InterleukinsIBA
11/2017 - 04/2012
3Interleukin-6 (Interleukin 6)IBA
07/2017 - 04/2012
3CytokinesIBA
01/2017 - 12/2013
3Anticonvulsants (Antiepileptic Drugs)IBA
08/2014 - 01/2002
3EnzymesIBA
01/2014 - 03/2007
3Indicators and Reagents (Reagents)IBA
12/2010 - 01/2008
2Growth Hormone (Somatotropin)IBA
02/2022 - 07/2021
2Glucose (Dextrose)FDA LinkGeneric
01/2022 - 06/2016
2Glutamine (L-Glutamine)FDA Link
10/2019 - 01/2008
2caffeic acidIBA
01/2018 - 01/2017
2coenzyme Q10 (CoQ10)IBA
08/2016 - 09/2007
2Matrix Metalloproteinases (MMPs)IBA
02/2016 - 12/2013
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2016 - 02/2010
2Atorvastatin (Lipitor)FDA Link
01/2016 - 02/2010
2LDL Lipoproteins (beta Lipoproteins)IBA
01/2016 - 01/2008
2ORALIT (ORS)IBA
12/2014 - 05/2010
2AutoantibodiesIBA
01/2013 - 12/2010
2Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA
01/2008 - 11/2004
2HomocysteineIBA
01/2008 - 11/2004
1Insulin-Like Growth Factor I (IGF-1)IBA
02/2022
1Oxidopamine (6 Hydroxydopamine)IBA
01/2021
1Electron Transport Complex III (Coenzyme Q-Cytochrome-c Reductase)IBA
01/2021
1Bromodeoxyuridine (BrdU)IBA
01/2020
1AdenineFDA LinkGeneric
11/2019
1GuanineIBA
11/2019
1CytosineIBA
11/2019
1cordycepinIBA
01/2019
1Ethanol (Ethyl Alcohol)IBA
01/2019
1Basigin (Extracellular Matrix Metalloproteinase Inducer (EMMPRIN))IBA
12/2018

Therapy/Procedure

11Therapeutics
02/2022 - 01/2002
6Transplantation
10/2020 - 10/2015
1Chemoprevention
01/2019
1Exercise Therapy (Therapy, Exercise)
10/2018